31. On Thursday, Lilly said it was abandoning the development of an enhanced form of the antidepressant Prozac following a new evalution of clinical data. |
31. On Thursday, Lilly said it was abandoning the development of an enhanced form of the antidepressant Prozac following a new evalution of clinical data. |